SecBot SecBot
COURT-RULING ·Filed Mar 2, 2026

KR

KROGER CO
NEUTRAL
Impact 4/10
Horizonmonths Processed5mo ago CourtCourt Ruling · courtlistener.com
Court ruling (district)
Actionable Insight • Neutral

This ruling keeps Kroger's antitrust claims alive but is early-stage procedural. Monitor for summary judgment motions and potential settlement developments in the MDL. The case remains in discovery phase, no immediate financial impact on Kroger.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$67.82
T+0 close · Mar 3, 2026 · via day close
Latest settled
−6.77%
T+60 · $63.23
Vs SPY
−17.99%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 3 $67.82entry
  2. T+1 · 9mo ago −0.95%α −1.65% · $67.17
  3. T+5 · 8mo ago +5.24%α +5.71% · $71.37
  4. T+20 · 8mo ago +5.42%α +9.57% · $71.49
  5. T+60 · 6mo ago −6.77%α −17.99% · $63.23
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

In the Generic Pharmaceuticals MDL 2724 antitrust litigation, the court denied Epic Pharma's motions to dismiss claims against it in eight of eleven complaints, including the one filed by The Kroger Co. The Kroger complaint survived because it sufficiently alleged Epic conspired with Lannett and Actavis to fix prices of Ursodiol, including a 1000% price increase by Epic. This ruling keeps Kroger's antitrust claims alive, preserving the potential for damages recovery, but is an interlocutory procedural ruling, not a final judgment, so no damages have been awarded.

Court Ruling Details

Ruling Date
Feb 27, 2026
Court
United States District Court for the Eastern District of Pennsylvania
Court Level
District
Judge
Cynthia M. Rufe
Case Type
antitrust
Ruling Type
motion to dismiss
Outcome
PARTIAL: mixed ruling, some claims won/lost
Precedent Risk
LOW

Key Facts

  • Kroger is one of 11 plaintiffs in the Generic Pharmaceuticals MDL 2724 antitrust litigation against Epic Pharma.
  • The court denied Epic's motion to dismiss Kroger's complaint, allowing the case to proceed.
  • Kroger's complaint alleges Epic conspired with Lannett and Actavis to raise Ursodiol prices, including a 1000% price increase by Epic.
  • Three other complaints (HCSC, Molina, CVS) were dismissed for failing to adequately plead Epic's involvement.
  • This is a motion-to-dismiss ruling under Rule 12(b)(6), not a final judgment on the merits.
  • No damages have been awarded; the ruling only determines the complaint states a plausible claim.

Financial Impact

No damages awarded or quantified in the ruling. Potential exposure for Epic is not stated.

Risk Factors

  • Kroger must still prove its allegations at trial or through summary judgment.
  • Appeals or further motions could still result in dismissal.
  • The MDL has been ongoing for nearly a decade, resolution timeline is uncertain.

Market Snapshot

Exchange
NYSE
Sector
Retail-Grocery Stores
Analyst Consensus
58% bullish (33 analysts)

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-lvpf066w-KR

Track record

26 reports on KR

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +18.96% at T+60 after the May 19, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 4/10 Entry price pending
  2. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $65.02 Now $70.67 +8.69% settles Nov 25
  3. Oct 23, 202624d ago Institutional Cluster Neutral 3/10 Entry $66.77 Now $70.67 +5.84% settles Nov 20
  4. Oct 20, 202627d ago 8-K Neutral 5/10 Entry $62.98 Now $70.67 +12.21% settles Nov 17
  5. Oct 5, 20266w ago 8-K Neutral 3/10 Entry $58.78 to $66.76 Now $70.67 +20.23% ▲ +13.58% +16.04% vs SPY
  6. Sep 30, 20266w ago Court Ruling Neutral 3/10 Entry $59.48 to $65.93 Now $70.67 +18.81% ▲ +10.84% +10.14% vs SPY
  7. Sep 28, 20267w ago 424B5 Neutral 3/10 Entry $59.69 to $66.77 Now $70.67 +18.40% ▲ +11.86% +11.89% vs SPY
  8. Sep 25, 20267w ago Press Release Neutral 2/10 Entry $58.74 to $66.77 Now $70.67 +20.31% ▲ +13.67% +15.15% vs SPY
  9. Sep 17, 20268w ago Press Release Neutral 2/10 Entry $60.00 to $63.63 Now $70.67 +17.78% ▲ +6.05% +5.85% vs SPY
  10. Sep 11, 20269w ago 8-K Mixed 5/10 Entry $58.49 to $61.64 Now $70.67 +20.82% ▲ +5.39% +3.52% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (11h 44m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published Jun 3, 2026